XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,571,120 | -11.6% | 192,363 | -0.3% | 0.02% | -8.0% |
| Q2 2023 | $7,431,848 | +9.1% | 193,035 | +1.4% | 0.02% | +8.7% |
| Q1 2023 | $6,813,700 | -9.4% | 190,380 | -0.2% | 0.02% | -14.8% |
| Q4 2022 | $7,523,007 | -45.7% | 190,794 | -50.3% | 0.03% | 0.0% |
| Q3 2022 | $13,850,280 | +19.0% | 383,672 | +0.3% | 0.03% | +22.7% |
| Q2 2022 | $11,641,897 | -2.4% | 382,702 | -1.9% | 0.02% | +29.4% |
| Q1 2022 | $11,925,740 | +95.7% | 390,104 | +100.0% | 0.02% | +6.2% |
| Q4 2021 | $6,093,000 | +149.8% | 195,048 | +22.2% | 0.02% | +128.6% |
| Q3 2021 | $2,439,000 | – | 159,643 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |